Janney Montgomery Scott’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$146M Sell
416,010
-15,043
-3% -$5.36M 0.36% 55
2025
Q4
$141M Buy
431,053
+40,622
+10% +$12.9M 0.32% 62
2025
Q3
$110M Buy
390,431
+3,593
+0.9% +$1.04M 0.26% 85
2025
Q2
$108M Sell
386,838
-24,724
-6% -$7M 0.28% 69
2025
Q1
$128M Buy
411,562
+35,100
+9% +$10.4M 0.36% 54
2024
Q4
$98.1M Sell
376,462
-58,256
-13% -$17.3M 0.27% 76
2024
Q3
$140M Buy
434,718
+7,516
+2% +$2.46M 0.39% 56
2024
Q2
$133M Buy
427,202
+113,421
+36% +$33.3M 0.41% 49
2024
Q1
$89.2M Buy
313,781
+21,824
+7% +$6.39M 0.27% 76
2023
Q4
$84.1M Sell
291,957
-22,780
-7% -$6.21M 0.27% 70
2023
Q3
$84.6M Buy
314,737
+20,354
+7% +$5.08M 0.32% 65
2023
Q2
$65.4M Buy
+294,383
New +$68.3M 0.23% 93
2023
Q1
Sell
-264,922
Closed -$69.6M 2492
2022
Q4
$69.6M Buy
264,922
+26,632
+11% +$7.14M 0.27% 79
2022
Q3
$53.7M Buy
+238,290
New +$57.8M 0.23% 93
2021
Q1
Sell
-257,621
Closed -$59.2M 2190
2020
Q4
$59.2M Buy
257,621
+24,182
+10% +$5.58M 0.29% 84
2020
Q3
$59.3M Sell
233,439
-7,055
-3% -$1.75M 0.34% 71
2020
Q2
$56.7M Buy
240,494
+38,929
+19% +$8.88M 0.36% 64
2020
Q1
$40.9M Buy
201,565
+20,461
+11% +$4.47M 0.32% 78
2019
Q4
$43.7M Buy
181,104
+6,048
+3% +$1.33M 0.29% 83
2019
Q3
$33.9M Sell
175,056
-1,313
-0.7% -$252K 0.25% 95
2019
Q2
$32.5M Buy
176,369
+240
+0.1% +$43K 0.25% 95
2019
Q1
$33.5M Sell
176,129
-5,245
-3% -$1M 0.28% 89
2018
Q4
$35.3M Buy
181,374
+2,370
+1% +$462K 0.34% 67
2018
Q3
$37.1M Sell
179,004
-2,748
-2% -$542K 0.32% 75
2018
Q2
$33.5M Buy
181,752
+6,039
+3% +$1.07M 0.32% 69
2018
Q1
$30M Sell
175,713
-36,548
-17% -$6.71M 0.3% 82
2017
Q4
$36.9M Buy
212,261
+9,303
+5% +$1.65M 0.38% 66
2017
Q3
$37.8M Buy
202,958
+10,860
+6% +$1.92M 0.43% 52
2017
Q2
$33.1M Buy
192,098
+10,521
+6% +$1.71M 0.41% 60
2017
Q1
$29.8M Buy
181,577
+17,660
+11% +$2.93M 0.4% 59
2016
Q4
$24M Buy
163,917
+17,587
+12% +$2.65M 0.36% 62
2016
Q3
$24.4M Buy
+146,330
New +$24.7M 0.43% 53
2016
Q2
Sell
-99,310
Closed -$14.9M 664
2016
Q1
$14.9M Buy
99,310
+4,009
+4% +$596K 0.39% 55
2015
Q4
$15.5M Sell
95,301
-1,554
-2% -$244K 0.4% 58
2015
Q3
$13.4M Buy
+96,855
New +$15.3M 0.38% 60
2015
Q2
Sell
-84,042
Closed -$13.4M 2033
2015
Q1
$13.4M Buy
84,042
+3,771
+5% +$594K 0.25% 81
2014
Q4
$12.8M Buy
80,271
+24,795
+45% +$3.86M 0.26% 72
2014
Q3
$7.79M Buy
55,476
+4,969
+10% +$649K 0.16% 141
2014
Q2
$5.98M Buy
50,507
+9,745
+24% +$1.13M 0.13% 183
2014
Q1
$5.03M Buy
40,762
+4,141
+11% +$502K 0.12% 201
2013
Q4
$4.18M Buy
36,621
+1,343
+4% +$153K 0.11% 214
2013
Q3
$3.95M Buy
35,278
+22,911
+185% +$2.48M 0.12% 204
2013
Q2
$1.22M Buy
+12,367
New +$1.28M 0.13% 193

Other funds holding AMGN

Janney Montgomery Scott's AMGN Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Amgen (AMGN) stake by 3.5% in Q1 2026, selling an estimated $5.36M and leaving 416,010 shares worth $146M. The position accounts for 0.36% of the portfolio, ranked #55.

Janney Montgomery Scott first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Janney Montgomery Scott held 416,010 shares of Amgen worth $146M as of Q1 2026.
  • Janney Montgomery Scott sold 15,043 Amgen shares in Q1 2026, an estimated $5.36M.
  • Amgen made up 0.36% of Janney Montgomery Scott's portfolio in Q1 2026, its #55 holding.
  • Janney Montgomery Scott first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.